Dr. Ankur Bindal is the President and Co-Founder of the Southern California-based Aroga Group, a real estate investment and management firm established in 2020. He oversees residential and commercial investing, development, holding, and management services, guiding the organization with a long-term strategy focused on stability, scalable growth, and disciplined decision-making informed by his extensive leadership background. In addition to his work in real estate, Ankur Bindal is the founder of KAB Medical Group, also known as KMG Psychiatry, with locations in San Diego and Los Angeles. He served as Chief Executive Officer and President for nearly ten years, during which he built a highly regarded integrative psychiatry practice. He later transitioned from daily clinical operations to focus entirely on entrepreneurial and investment ventures. A board-certified psychiatrist and sleep specialist, Dr. Bindal’s clinical career has emphasized comprehensive and individualized care. He provided traditional psychiatric services such as medication management and counseling, while also implementing advanced treatments including Transcranial Magnetic Stimulation therapy and intranasal Ketamine treatment. His integrative approach was designed to improve outcomes for patients who had not responded to conventional treatment alone. Dr. Bindal gained international recognition for his expertise in brain stimulation therapies, particularly Transcranial Magnetic Stimulation. His work served a diverse patient population, including former professional athletes, healthcare professionals, executives, and underserved individuals from around the world. These efforts earned him Diamond Circle Provider status and Outstanding Leadership and Outstanding Corporation Awards at Health Conference 2.0 in 2023. His professional achievements include being named a Top Doctor and leading KMG Psychiatry to be voted Best in San Diego in 2024 and 2025. Patient satisfaction ratings consistently ranged from 4.8 to 5.0, reflecting trust, clinical excellence, and a patient-centered approach. He has also received numerous honors, including the APA Diversity Leadership Award and several national academic distinctions. Beyond his business and clinical accomplishments, Dr. Ankur Bindal has served on multiple healthcare and regulatory boards, including a term on the Department of Consumer Affairs Structural Pest Control Board from 2022 to 2025. He is a published contributor to Forbes, a frequent speaker on leadership and entrepreneurship, and an active supporter of charitable organizations. He values time with his wife, daughter, and dog.